Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19338548.
- Also identified by DOI 10.1111/j.1464-410X.2009.08446.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the past decade several advances have been made in the field of nuclear magnetic resonance (NMR) imaging. MR spectroscopic imaging (MRSI) is one such advance which holds promise for detecting biochemical change on imaging of the prostate, and that can be used in several ways for improving the management of patients with prostate cancer. We review the literature, technique and basics of MRSI, with its current status in various situations as applied to the management of prostate cancer.
Medical subject headings
- Magnetic Resonance Spectroscopy
- Prostate
- Prostatic Neoplasms